At a Glance
7thirty Capital operates as a specialized venture capital firm focused on the intersection of cannabis technology and traditional sectors including medical technology, agricultural technology, and software-as-a-service platforms. Based in New York, the firm has positioned itself within a niche but rapidly expanding market segment that emerged following increased cannabis legalization across U.S. states. The firm's investment strategy centers on companies that provide technology infrastructure, compliance solutions, and operational efficiency tools for cannabis businesses, as well as ancillary services that support the broader cannabis ecosystem. 7thirty Capital typically writes checks ranging from seed to Series A stages, targeting companies that can benefit from both the cannabis market expansion and broader technology adoption trends. The firm's portfolio approach reflects an understanding that cannabis businesses face unique regulatory, banking, and operational challenges that create opportunities for specialized technology solutions. Their investments often focus on B2B software platforms that help cannabis companies manage compliance, inventory, point-of-sale systems, and supply chain logistics. The New York-based firm has also shown interest in medical technology applications that leverage cannabis or hemp-derived compounds, positioning at the convergence of pharmaceutical development and cannabis research. 7thirty Capital's market position reflects the maturation of cannabis investing, moving beyond direct plant-touching businesses toward the technology and services infrastructure that supports the industry. The firm represents part of a new generation of specialized cannabis investors that emerged as institutional capital became more comfortable with the sector following state-level legalization trends. Their SaaS focus aligns with broader venture capital trends toward recurring revenue business models, while their agricultural technology investments tap into both cannabis cultivation optimization and the broader agtech market expansion.
“Cannabis-technology specialist in med-tech, ag-tech, and SaaS.”
7thirty Capital's fund progression and specific fundraising history details are not widely disclosed in public venture capital databases. As a firm founded in 2017 during the early expansion of state-level cannabis legalization, the firm's fund development likely coincided with increasing institutional investor interest in cannabis-adjacent technology investments, though specific fund sizes, investor composition, or performance metrics have not been publicly reported.
7thirty Capital primarily invests at the Seed, Series A stages. This means they focus on companies that are building their initial product and finding product-market fit.
7thirty Capital is headquartered in New York, NY. Many of their portfolio companies are also based in this region, though they invest across geographies.
7thirty Capital focuses on investments in Agriculture, SaaS, Other. Their portfolio reflects deep expertise and networks within these sectors.
7thirty Capital's typical investment check size ranges from $100K to $1M. Actual amounts may vary based on the stage, sector, and specific opportunity.
